Otsuka, Proteus finally win FDA approval for sensor-equipped Abilify

The first drug in the US with a digital ingestion tracking system has been approved by the FDA. The pill, Abilify MyCite, is prescribed for treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and as an add-on treatment for depression in adults.
Source: mobihealthnews - Category: Information Technology Source Type: news